Discontinuation report SANDOZ RISPERIDONE
Report ID | 144338 |
Drug Identification Number | 02279800 |
Brand name | SANDOZ RISPERIDONE |
Common or Proper name | SANDOZ RISPERIDONE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | RISPERIDONE |
Strength(s) | 1.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 60FCT UD CA |
ATC code | N05AX |
ATC description | ANTIPSYCHOTICS |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | |
Actual discontinuation date | 2021-08-13 |
Remaining supply date | 2021-08-13 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | New packaging; transition to new format of bottle of 100 tablets |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2021-08-19 | French | Compare |
v2 | 2021-08-19 | English | Compare |
v1 | 2021-08-19 | English | Compare |
Showing 1 to 3 of 3